Disease Attributes
8 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| 68Ga-HTK03149 for Use as a Diagnostic Radiopharmaceutical (NCT04831307) | British Columbia Cancer Agency | 2021-08-30 |
| Strategy to Avoid Excessive Oxygen in Major Burn Patients (NCT04534972) | University of Colorado, Denver | 2021-04-15 |
| Strategy to Avoid Excessive Oxygen for Critically Ill Trauma Patients (NCT04534959) | University of Colorado, Denver | 2020-10-15 |
| Vorasidenib Expanded Access Program (NCT05592743) | Servier |
Track Disease Attributes automatically
Every clearance here is in the API, with alerts when new ones post.